title: Clinical practice guidelines for evidence-based use of erythropoietic-stimulating agents.
authors.affiliation: Department of Medicine, University of Western Ontario, London, Ontario, Canada.
authors.forename: Louise M
authors.initials: LM
authors.lastname: Moist
authors.forename: Rob N
authors.initials: RN
authors.lastname: Foley
authors.forename: Brendan J
authors.initials: BJ
authors.lastname: Barrett
authors.forename: Francois
authors.initials: F
authors.lastname: Madore
authors.forename: Colin T
authors.initials: CT
authors.lastname: White
authors.forename: Scott W
authors.initials: SW
authors.lastname: Klarenbach
authors.forename: Bruce F
authors.initials: BF
authors.lastname: Culleton
authors.forename: Marcello
authors.initials: M
authors.lastname: Tonelli
authors.forename: Braden J
authors.initials: BJ
authors.lastname: Manns
mesh_terms: D000740:Anemia / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D015415:Biomarkers / Q000097:blood; D035843:Biomedical Research; D004334:Drug Administration Schedule; D016903:Drug Monitoring; D004349:Drug Packaging; D019317:Evidence-Based Medicine; D006397:Hematinics / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007501:Iron / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D006435:Renal Dialysis; D016896:Treatment Outcome
chemical_list: D015415:Biomarkers; D006397:Hematinics; D006454:Hemoglobins; D007501:Iron